← Open Payments lookup

JESSICA NELSON: Open Payments

NPI 1659603017 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$477 in 9 payments from 8 companies in 2025. Trend: 2023 $954 · 2024 $419 · 2025 $477

Food & beverage: $477
CompanyPaymentsAmount
Baxter Healthcare1$146
Astellas Pharma US Inc1$135
Amgen Inc.1$63
Sumitomo Pharma America, Inc.2$41
Novo Nordisk Inc1$27
Calliditas Therapeutics US Inc.1$24
Ethicon US, LLC1$22
Caris MPI, Inc.1$20

Products named: FLOSEAL, Xtandi, IMDELLTRA (AMG757), GEMTESA, Rivfloza, TARPEYO, Echelon; Endopath, MI CANCER SEEK.

Industry payments across TX — which companies pay providers there.